Jinxin Fertility Group (HKSE:01951) Cash, Cash Equivalents, Marketable Securities : HK$933 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Jinxin Fertility Group Cash, Cash Equivalents, Marketable Securities?

Jinxin Fertility Group's quarterly cash, cash equivalents, marketable securities declined from Dec. 2022 (HK$1,564.79 Mil) to Jun. 2023 (HK$1,144.30 Mil) but then stayed the same from Jun. 2023 (HK$1,144.30 Mil) to Dec. 2023 (HK$932.88 Mil).

Jinxin Fertility Group's annual cash, cash equivalents, marketable securities declined from Dec. 2021 (HK$2,360.80 Mil) to Dec. 2022 (HK$1,564.79 Mil) and declined from Dec. 2022 (HK$1,564.79 Mil) to Dec. 2023 (HK$932.88 Mil).

Jinxin Fertility Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Jinxin Fertility Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinxin Fertility Group Cash, Cash Equivalents, Marketable Securities Chart

Jinxin Fertility Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

3,667.76

2,927.05

2,360.80

1,564.79

932.88

Jinxin Fertility Group Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial									2,360.80	1,619.88	1,564.79	1,144.30	932.88

Jinxin Fertility Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Jinxin Fertility Group (HKSE:01951) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Jinxin Fertility Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Jinxin Fertility Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinxin Fertility Group (HKSE:01951) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jinxin Fertility Group Ltd (HKSE:01951) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

3NX:Germany

Address

No. 301, North Jingsha Road, Jinjiang District, Sichuan, Chengdu, CHN

Website

https://www.jxr-fertility.com

Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm generates its revenue from Assisted reproductive services, management services, and ancillary medical services. Geographically, it generates a majority of its revenue from the People's Republic of China.

Executives

Jinxin Fertility Investment Group Limited	2101 Beneficial owner
Hrc Investment Holding, Llc
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Blackrock, Inc.	2201 Interest of corporation controlled by you
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

Jinxin Fertility Group (HKSE:01951) Headlines

No Headlines